Yayın:
Accurate and sensitive determination of hydroxychloroquine sulfate used on COVID-19 patients in human urine, serum and saliva samples by GC-MS

dc.contributor.authorBodur, Suleyman
dc.contributor.authorErarpat, Sezin
dc.contributor.authorGunkara, Omer Tahir
dc.contributor.authorBakirdere, Sezgin
dc.date.accessioned2026-06-27T14:37:27Z
dc.date.issued2021
dc.description.abstractA rapid, accurate, and sensitive analytical method, ultrasonication-assisted spraying based fine droplet formation-liquid phase microextraction-gas chromatography-mass spectrometry (UA-SFDF-LPME-GCMS), was proposed for the determination of trace amounts of hydroxychloroquine sulfate in human serum, urine, and saliva samples. To determine the best extraction strategy, several liquid and solid phase extraction methods were investigated for their efficiencies in isolation and preconcentration of hydroxychloroquine sulfate from biological matrices. The UA-SFDF-LPME method was determined to be the best extraction method as it was operationally simple and provided accurate results. Variables such as the extraction solvent, spraying number, sodium hydroxide concentration and volume, sample volume, mixing method, and mixing period were optimized for the proposed method using the one variable-at-a-time approach. In addition, Tukey's method based on a post hoc comparison test was employed to evaluate the significant difference between the parameters inspected. After the optimization studies, the limit of detection (LOD) and limit of quantification (LOQ) were determined to be 0.7 and 2.4 mg/kg, respectively. The sensitivity of the GC-MS system based on the LOD was enhanced approximately 440-fold when the UA-SFDF-LPME method was employed. Spiking experiments were also conducted for the human serum, urine, and saliva samples to determine the applicability and accuracy of the proposed method. Recoveries for the human serum, urine, and saliva samples were found to be in the ranges of 93.9%-101.7%, 95.2%-105.0%, and 93.1%-102.3%, respectively. These results were satisfactory and indicated that the hydroxychloroquine sulfate level in the above biological samples could be analyzed using the proposed method. (C) 2021 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).en
dc.description.sponsorshipHealth Institutes of Turkey (TUSEB) [2020CV01-8946]
dc.description.urihttps://doi.org/10.1016/j.jpha.2021.01.006
dc.identifier.doi10.1016/j.jpha.2021.01.006
dc.identifier.eissn2214-0883
dc.identifier.endpage283
dc.identifier.issn2095-1779
dc.identifier.issue3
dc.identifier.pubmed33552628
dc.identifier.startpage278
dc.identifier.urihttps://hdl.handle.net/20.500.14981/62797
dc.identifier.volume11
dc.identifier.wos000668581500004
dc.language.isoeng
dc.publisherELSEVIER
dc.relation.ispartofJOURNAL OF PHARMACEUTICAL ANALYSIS
dc.rightsopenAccess
dc.subjectHydroxychloroquine sulfate
dc.subjectGC-MS
dc.subjectBiological samples
dc.subjectDispersive solid phase extraction
dc.subjectLiquid phase microextraction
dc.subjectLIQUID-PHASE MICROEXTRACTION
dc.subjectQUANTIFICATION
dc.subjectEXTRACTION
dc.subjectPharmacology & Pharmacy
dc.titleAccurate and sensitive determination of hydroxychloroquine sulfate used on COVID-19 patients in human urine, serum and saliva samples by GC-MS
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar